Issue №6-20, 2021

Review article

https://doi.org/10.38025/2078-1962-2021-20-6-96-102

Modern Approaches to Diagnostics and Correction of Aging Biomarkers

View article (Download PDF file)



Download XML file

1 ORCIDIlmira R. Gilmutdinova, 1 ORCIDIrina S. Kudryashova, 1 ORCIDElena Yu. Kostromina, 1 ORCIDMaksim Yu. Yakovlev, 1 ORCIDInessa Kh. Yafarova, 2 ORCIDRinat G. Gilmutdinov, 2 ORCIDIrina A. Kaverina, 3 ORCIDAnton V. Ershov, 4 ORCIDAndrey N. Isaev, 5,6 ORCIDAlexey A. Moskalev

1 National Medical Research Center of Rehabilitation and Balneology, Moscow, Russian Federation
2 Orenburg Regional Clinical Blood Transfusion Station, Orenburg, Russian Federation
3 First Moscow State Medical University named after I.M. Sechenov, Moscow, Russian Federation
4 Limited Liability Company “DNKOM”, Moscow, Russian Federation
5 Institute of Biology of the Komi Scientific Center, Ural Branch of the Russian Academy of Sciences, Syktyvkar, Russian Federation
6 Pirogov Russian National Research Medical University, Moscow, Russian Federation


ABSTRACT

From the biomedicine point of, view ageing is a natural process, characterized by a gradual decrease in the physiological integrity and adaptive abilities of the body, leading to a violation of its functions and an increase in the risk of death with age. Demographic aging of the population is a serious socio-economic problem, both in Russia and around the world. The main cellular and molecular signs of aging include genome instability, telomere shortening, epigenetic alterations, impaired proteostasis, impaired nutrient recognition, mitochondrial dysfunction, cellular aging, the stem cell pool depletion and changes in intercellular interaction, extracellular matrix rigidity, as well as activation of retrotransposons and chronic inflammation. For these reasons, in modern healthcare, preventing premature aging and treating age-related diseases is becoming a priority task.

This review presents modern approaches to the quantitative assessment of the aging process using aging biomarkers as functional parameters reflecting the biological organism age at the molecular, cellular, and organismal levels. This work also considers the actual non-drug and drug interventions allowing to slow down the development of age-associated pathological processes, allowing you to increase the quality and duration of life.


KEYWORDS: aging biomarkers, geroprotectors, cellular aging therapy, epigenetic cell reprogramming, hemocorrection, plasmapheresis

Acknowledgments: The study had no sponsorship

Конфликт интересов: Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи

For citation: Gilmutdinova I.R., Kudryashova I.S., Kostromina E.Yu., Yakovlev M.Yu., Yafarova I.Kh., Gilmutdinov R.G., Kaverina I.A., Ershov A.V., Isaev A.N., Moskalev A.A. Modern Approaches to Diagnostics and Correction of Aging. Bulletin of Rehabilitation Medicine. 2021; 20 (6): 96-102. https://doi.org/10.38025/2078-1962-2021-20-6-96-102



References:

  1. Shcherbakova E.M. Demograficheskiy barometr. Starshiye pokoleniya naseleniya Rossii [Demographic barometer. Older generations of the population of Russia]. Demoscope Weekly. 2019; (797-798). (In Russ.).
  2. Maresova P., Javanmardi E., Barakovic S., Barakovic Husic J., Tomsone S., Krejcar O. et al. Consequences of chronic diseases and other limitations associ- ated with old age – a scoping review. BMC Public Health. 2019; 19(1): 1-17. https://doi.org/10.1186/S12889-019-7762-5
  3. Proshkina E.N., Solovyov I.A., Shaposhnikov M.V., Moskalev A.A. Klyuchevyye molekulyarnyye mekhanizmy stareniya, biomarkery i potentsial’nyye interventsii [Key molecular mechanisms of aging, biomarkers and potential interventions]. Molekulyarnaya Biologiya. 2020; 54(6): 883-921. https://doi.org/10.31857/S0026898420060099 (In Russ.).
  4. Anisimov V.N. Molekulyarnyye i fiziologicheskiye mekhanizmy stareniya [Molecular and physiological mechanisms of aging]. The Science. St. Peters- burg. 2008: 240 p. (In Russ.).
  5. López-Otín C., Blasco M.A., Partridge L., Serrano M., Kroemer G. The Hallmarks of Aging. Cell. 2013; 153(6): 1194-217. https://doi.org/10.1016/J.CELL.2013.05.039
  6. Fedintsev A., Moskalev A. Stochastic non-enzymatic modification of long-lived macromolecules – A missing hallmark of aging. Ageing Research Reviews. 2020; (62): 101097 p. https://doi.org/10.1016/j.arr.2020.101097
  7. Selman M., Pardo A. Fibroageing: An ageing pathological feature driven by dysregulated extracellular matrix-cell mechanobiology. Ageing Research Reviews. 2021; (70): 101393. https://doi.org/10.1016/j.arr.2021.101393
  8. Franceschi C., Garagnani P., Parini P. et al. Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nature Reviews Endocrinology. 2018; (14): 576-590. https://doi.org/10.1038/s41574-018-0059-4
  9. Khalyavkin A.V., Krutko V.N. Ot chego my stareyem i mozhno li vliyat’ na etot protsess [From what we are aging and whether it is possible to influence this process]. Bulletin of Rehabilitation Medicine. 2018; 1(83); 38-40 (In Russ.).
  10. Trukhanov A.I., Skakun S.G., Grechko A.V. Sovremennaya rol’ personifitsirovannoy tsifrovoy meditsiny v razvitii meditsinskoy reabilitatsii [The modern role of personalized digital medicine in the development of medical rehabilitation]. Bulletin of Rehabilitation Medicine. 2018; 1(83); 2-13 (In Russ.).
  11. Hartmann A., Hartmann C., Secci R., Hermann A., Fuellen G., Walter M. Ranking Biomarkers of Aging by Citation Profiling and Effort Scoring. Frontiers in Genetics. 2021; (12): 1-15. https://doi.org/10.3389/FGENE.2021.686320
  12. Ayroldi E., Cannarile L., Adorisio S., Delfino D.V., Riccardi C. Role of Endogenous Glucocorticoids in Cancer in the Elderly. International Journal of Molecu- lar Sciences. 2018; V.19: 3774 p. https://doi.org/10.3390/IJMS19123774
  13. Willey J.Z., Moon Y.P., Husain S.A., Elkind M.S.V., Sacco R.L., Wolf M. et al. Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study. PLOS One. 2020; 15(1): 1-26. https://doi.org/10.1371/JOURNAL.PONE.0226509
  14. Moskalev A., Chernyagina E., Kudryavtseva A., Shaposhnikov M. Geroprotectors: A Unified Concept and Screening Approaches. Aging and Disease. 2017; 8(3): 354 p. https://doi.org/10.14336/AD.2016.1022
  15. Moskalev A.A., Shaposhnikov M.V., Solovev I.A. Studying the geroprotective effects of inhibitors suppressing aging-associated signaling cascades in model organisms. Medical News of North Caucasus. 2017; 12(3): 342-7.
  16. Gonzalez-Freire M., Diaz-Ruiz A., Hauser D., Martinez-Romero J. et al. The road ahead for health and lifespan interventions. Ageing Research Reviews. 2020; (59). https://doi.org/10.1016/J.ARR.2020.101037
  17. Yamakawa H., Kusumoto D., Hashimoto H., Yuasa S. Stem Cell Aging in Skeletal Muscle Regeneration and Disease. International Journal of Molecular Sciences. 2020; V.21: 1830 p. https://doi.org/10.3390/IJMS21051830
  18. Ling Liu, Gregory W. Charville, Tom H. Cheung, Bryan Yoo, Pauline J. Santos, Matthew Schroeder, Thomas A. Rando. Impaired Notch Signaling Leads to a De- crease in p53 Activity and Mitotic Catastrophe in Aged Muscle Stem Cells. Cell Stem Cell. 2018; 23(4): 544-556.e4. https://doi.org/10.1016/J.STEM.2018.08.019
  19. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4): 663-76. https://doi.org/10.1016/J.CELL.2006.07.024
  20. Sogabe Y., Seno H., Yamamoto T., Yamada Y. Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology. Cancer Science. 2018; 109(9): 2641 p. https://doi.org/10.1111/CAS.13731
  21. Gowing G., Svendsen S., Svendsen C. Ex vivo gene therapy for the treatment of neurological disorders. Progress in Brain Research. 2017; (230): 99-132. https://doi.org/10.1016/BS.PBR.2016.11.003
  22. Sugaya K., Vaidya M. Exosomes, Stem Cells and MicroRNA. 2018; (1056): 61-84. 
  23. Davidsohn N., Pezone M., Vernet A., Graveline A. et al. A single combination gene therapy treats multiple age-related diseases. Proceedings of the Na- tional Academy of Sciences of the United States of America. 2019; 116(47): 23505-11. https://doi.org/10.1073/PNAS.1910073116
  24. Kim J.H., Hwang K.H., Park K.S., Kong I.D., Cha S.K. Biological Role of Anti-aging Protein Klotho. American Journal of Lifestyle Medicine. 2015; 5(1): 1 p. https://doi.org/10.15280/JLM.2015.5.1.1
  25. Horvath S., Singh K., Raj K., Khairnar S., Sanghavi A., Shrivastava A. et al. Reversing age: dual species measurement of epigenetic age with a single clock. bioRxiv. 2020. https://doi.org/10.1101/2020.05.07.082917 
  26. Gilmutdinova I.R., Eremin P.S. Predposylki k ispol’zovaniyu plazmafereza v kompleksnoy terapii i reabilitatsii onkologicheskikh bol’nykh [Prerequisites for the use of plasmapheresis in the complex therapy and rehabilitation of cancer patients]. Bulletin of Rehabilitation Medicine. 2020; 4(98); 131-134 (In Russ.).
  27. Xufeng Li, Jiren Zhang, Chen Sun, Yuanyuan Zhang, Rui Cai, Shilin Fu, Jingfen Zheng, and Dehai Huang. Application of biological age assessment of Chinese population in potential anti-ageing technology. Immun Ageing. 2018; (15): 33 p.



Creative Commons License
The content is available under the Creative Commons Attribution 4.0 License.

©

Эта статья открытого доступа по лицензии CC BY 4.0. Издательство: ФГБУ «НМИЦ РК» Минздрава России.
This is an open article under the CC BY 4.0 license. Published by the National Medical Research Center for Rehabilitation and Balneology.

Aссоциация НАЭСКЛ